Tooth Margaret sold $26K of TRUP

Tooth Margaret (CEO) sold 1,000 shares of TRUPANION, INC. (TRUP) at $25.84 on 2026-10-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tooth Margaret
Published Oct 13, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

This provides incremental sentiment information about insider behavior but does not change company fundamentals or near-term expectations.

02

Market read

Traders may note the insider sale for sentiment, but the small dollar amount and 10b5-1 plan suggest limited tradable impact.

03

What to watch

The article does not indicate whether the CEO also bought shares, nor does it provide broader insider activity context beyond this single sale.

Relevance 2/10Novelty 2/10Timing: filed after-hours Oct. 13, reflecting the Oct. 9 sale

Background

The filing is an SEC Form 4 insider transaction for TRUP, reported as an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUP insider Form 4 shows CEO Tooth Margaret sold 1,000 shares at $25.84 on a pre-arranged 10b5-1 plan, filed Oct. 13.

Expected impact

Shares may face slight overhead from the optics of an insider sale, though impact is likely limited given the pre-arranged 10b5-1 plan.

Evidence & confidence

The transaction is small ($25,840) and explicitly tied to a pre-arranged 10b5-1 plan, which typically dampens market interpretation versus discretionary selling.

Market effects

Minimal, as this is a routine, small-scale insider sale with no operational or guidance change.

None.

None.

Counterpoint

Because it is a pre-arranged 10b5-1 sale, the market may overreact; the filing can be largely noise for near-term price action.

Key entities

  • TRUPANION, INC.

    US-listed company whose CEO filed an SEC Form 4 for an insider sale under a 10b5-1 plan.

  • Tooth Margaret

    CEO and director who sold 1,000 shares at $25.8400 on Oct. 9, 2026.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMedAI 8/10

Why is Trupanion (TRUP) stock soaring today

Trupanion (TRUP) shares rose 6.5% after reporting Q3 2026 revenue of $405.6M, up 10.5% YoY, and EPS of $0.21, both exceeding estimates. The company also reported strong cash flow and share repurchases. The stock has been volatile, with a 52-week low reached after a Q4 2025 EPS miss.

$TRUPHighAI 8/10

Trupanion Q3 Earnings Call Highlights

Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.

$TRUPMed

Trupanion Inc (TRUP) Q3 2026 Earnings Call Highlights: Record Adjusted Operating Income

Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.

$TRUPHigh

Trupanion Reports Third Quarter 2026 Results

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.